![Sandra Cavanah Tucher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sandra Cavanah Tucher
Plus aucun poste en cours
Historique de carrière de Sandra Cavanah Tucher
Anciens postes connus de Sandra Cavanah Tucher
Sociétés | Poste | Début | Fin |
---|---|---|---|
Open Monoclonal Technology, Inc.
![]() Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Directeur Financier/CFO | 01/01/2007 | - |
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Open Monoclonal Technology, Inc.
![]() Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Sandra Cavanah Tucher
- Expérience